Login / Signup

The ANKS1B gene and its associated phenotypes: focus on CNS drug response.

Rabha M YounisRachel M TaylorPatrick M BeardsleyJoseph L McClay
Published in: Pharmacogenomics (2020)
The ANKS1B gene was a top finding in genome-wide association studies (GWAS) of antipsychotic drug response. Subsequent GWAS findings for ANKS1B include cognitive ability, educational attainment, body mass index, response to corticosteroids and drug dependence. We review current human association evidence for ANKS1B, in addition to functional studies that include two published mouse knockouts. The several GWAS findings in humans indicate that phenotypically relevant variation is segregating at the ANKS1B locus. ANKS1B shows strong plausibility for involvement in CNS drug response because it encodes a postsynaptic effector protein that mediates long-term changes to neuronal biology. Forthcoming data from large biobanks should further delineate the role of ANKS1B in CNS drug response.
Keyphrases
  • body mass index
  • adverse drug
  • endothelial cells
  • genome wide
  • copy number
  • randomized controlled trial
  • emergency department
  • systematic review
  • small molecule
  • case control
  • immune response
  • deep learning
  • dna methylation